White Papers and Resources
Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or edited by PMLiVE or PMGroup Worldwide Ltd.
Clinical trials explained: Why health literacy matters…
January 25, 2024 | White Papers and Resources |
Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed …
Brought to you by Cuttsy + Cuttsy
Inside Mednet’s Writing Academy: How do you mentor excellence?
January 24, 2024 | White Papers and Resources |
Medical Writer, Tayyibah Ali looks at how we mentor excellence within our team
Brought to you by Mednet
Patient Advocate Engagement: A Customer Story
January 22, 2024 | White Papers and Resources |
Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current …
Brought to you by Impetus Digital
Bringing omnichannel to medical affairs: what do you need to know?
January 16, 2024 | White Papers and Resources |
By Frank Fisher
Brought to you by Amiculum
Trends in Virtual Collaboration
January 15, 2024 | White Papers and Resources |
Join us for a look at the top-5 emerging virtual collaboration trends…
Brought to you by Impetus Digital
Unlock possibilities: A Medical Affairs strategy fit for the future
January 15, 2024 | White Papers and Resources |
Explore the key areas to include in a Medical Affairs strategy and plan that is fit for the future in our latest whitepaper.
Brought to you by OPEN Health
Why Words Matter: Person-first language in the age of identity
January 12, 2024 | White Papers and Resources |
We take a look at why the words we use in medcomms matter and examine the use of patient-first language
Brought to you by Mednet
On a journey to diverse, inclusive, and more efficient rare disease trials
January 5, 2024 | White Papers and Resources |
Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare …
Brought to you by Impetus Digital
Using generative AI in healthcare comms – our promise to our clients
December 14, 2023 | White Papers and Resources |
It’s safe to say one of the hottest topics of 2023 has been ChatGPT and the launch of other Generative AI-driven applications. So, we’re sharing …
Brought to you by Cuttsy + Cuttsy
Digital options to enhance your local market access materials
December 12, 2023 | White Papers and Resources |
How can a digital approach enhance local customer communication, particularly when tools are adapted from existing global materials? What are the options? How can we …
Brought to you by Petauri Evidence